FLAG-IDA FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA: A SINGLE CENTRE 5-YEAR STUDY

被引：0
|
作者：
Agbuduwe, C. [1 ]
Follows, G. [1 ]
Craig, J. [1 ]
Uttenthal, B. [1 ]
Crawley, C. [1 ]
Krishnamurthy, P. [1 ]
机构：
[1] Cambridge Univ Hosp NHS Trust, Haematol, Cambridge, England
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E938
引用
收藏
页码：385 / 385
页数：1
相关论文
共 50 条
  • [31] A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients
    Martinez Sanchez, Maria P.
    Megias-Vericat, Juan Eduardo
    Rodriguez-Veiga, Rebeca
    Vives, Susana
    Bergua, Juan Miguel
    Torrent, Anna
    Suarez-Varela, Sara
    Boluda, Blanca
    Martinez-Lopez, Joaquin
    Cano-Ferri, Isabel
    Acuna-Cruz, Evelyn
    Torres-Minana, Laura
    Martin-Herreros, Beatriz
    Serrano, Alfons
    Sempere, Amparo
    Barragan, Eva
    Sargas, Claudia
    Sanz, Miguel
    Martinez-Cuadron, David
    Montesinos, Pau
    ANNALS OF HEMATOLOGY, 2021, 100 (06) : 1497 - 1508
  • [32] CPX-351 Versus FLAG-IDA with or without Venetoclax in Previously Untreated and Relapsed or Refractory Acute Myeloid Leukemia
    Baoligny, Panellan
    Murray, Graeme
    Ho, Thuy
    Gor, Juhi
    Zacholski, Kyle
    Wages, Nolan
    Grant, Steven
    Maher, Keri
    BLOOD, 2023, 142
  • [33] FLAG-IDA as frontline induction or salvage therapy for patients with high risk and/or relapsed or refractory acute myeloid leukemia (AML)
    Bhella, Sita
    Atenafu, Eshetu G.
    Schuh, Andre C.
    Minden, Mark D.
    Schimmer, Aaron David
    Gupta, Vikas
    Seftel, Matthew D.
    Alam, Naheed
    Lutynski, Andrzej
    Rydlewski, Anna
    Rostom, Amr
    Yee, Karen W. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [34] Relapsed or primary refractory AML: moving past MEC and FLAG-ida
    Koenig, Kristin
    Mims, Alice
    CURRENT OPINION IN HEMATOLOGY, 2020, 27 (02) : 108 - 114
  • [35] FLAG-IDA: A HIGHLY EFFECTIVE SALVAGE REGIMEN IN PRIMARY REFRACTORY ACUTE MYELOID LEUKEMIA
    Virijevic, M.
    Suvajdzic-Vukovic, N.
    Djunic, I.
    Novkovic, A.
    Mitrovic, M.
    Colovic, N.
    Vidovic, A.
    Tomin, D.
    HAEMATOLOGICA, 2013, 98 : 520 - 520
  • [36] FLAG-ida as a stem cell mobilization regimen in patients with primary refractory or relapsed acute leukemia
    Cagirgan, S
    Pehlivan, M
    Donmez, A
    Talu, P
    Yilmaz, M
    Tombuloglu, M
    BONE MARROW TRANSPLANTATION, 2003, 31 : S257 - S257
  • [37] Clinical outcomes in patients with relapsed/refractory acute leukemia treated with FLAG-IDA regimen.
    Basquiera, Ana L.
    Prates, M. Virginia
    Sturich, Ana Gabriela
    Berretta, Adriana R.
    Milone, Jorge
    Garcia, Juan
    BLOOD, 2006, 108 (11) : 220B - 220B
  • [38] Comparison of Hidac Versus FLAG-IDA in the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Retrospective Study
    Tang, Man Wai
    van der Tuin, Deborah
    Aydin, Mesire
    Heijmans, Jarom
    van de Loosdrecht, Arjan A.
    Meijer, Ellen
    Rutten, Caroline E.
    Wondergem, Marielle
    Janssen, Jeroen J. W. M.
    Donker, Marjolein
    Hazenberg, Mette D.
    Zweegman, Sonja
    Biemond, Bart J.
    de Leeuw, David C.
    Nur, Erfan
    BLOOD, 2022, 140 : 3287 - 3289
  • [39] Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia
    Dinardo, Courtney D.
    Jen, Wei-Ying
    Takahashi, Koichi
    Kadia, Tapan M.
    Loghavi, Sanam
    Daver, Naval G.
    Xiao, Lianchun
    Reville, Patrick K.
    Issa, Ghayas C.
    Short, Nicholas J.
    Sasaki, Koji
    Wang, Sa A.
    Mullin, Jillian K.
    Pierce, Sherry
    Bradley, Corey
    Borthakur, Gautam
    Maiti, Abhishek
    Alvarado, Yesid
    Pemmaraju, Naveen
    Ferrajoli, Alessandra
    Swaminathan, Mahesh
    Ohanian, Maro
    Abbas, Hussein A.
    Hammond, Danielle
    Burger, Jan
    Haddad, Fadi
    Montalban-Bravo, Guillermo
    Chien, Kelly
    Masarova, Lucia
    Yilmaz, Musa
    Jain, Nitin
    Andreeff, Michael
    Garcia-Manero, Guillermo
    Kornblau, Steven
    Ravandi, Farhad
    Jabbour, Elias
    Konopleva, Marina Y.
    Kantarjian, Hagop M.
    LEUKEMIA, 2025, : 854 - 863
  • [40] Long term follow-up of refractory/relapsed acute myeloid leukemia patients treated with the FLAG-Ida regimen as bridge therapy to allotransplantation: 10-year results from a single centre experience
    Delia, Mario
    Gagliardi, Vito Pier
    Carluccio, Paola
    Attolico, Immacolata
    Contento, Corinne
    Di Gennaro, Daniela
    Albano, Francesco
    Musto, Pellegrino
    LEUKEMIA RESEARCH, 2023, 129
12345